tetano
Editor, Senior Moderator
J Korean Med Sci
. 2022 Jun 6;37(22):e78.
doi: 10.3346/jkms.2022.37.e78.
Impact of Mediastinal Lymphadenopathy on the Severity of COVID-19 Pneumonia: A Nationwide Multicenter Cohort Study
Jong Eun Lee[SUP] 1 [/SUP], Won Gi Jeong[SUP] 2 [/SUP], Bo Da Nam[SUP] 3 [/SUP], Soon Ho Yoon[SUP] 4 [/SUP], Yeon Joo Jeong[SUP] 5 [/SUP], Yun-Hyeon Kim[SUP] 1 [/SUP], Sung Jin Kim[SUP] 6 [/SUP], Jin Young Yoo[SUP] 7 [/SUP]
Affiliations
Abstract
Background: We analyzed the differences between clinical characteristics and computed tomography (CT) findings in patients with coronavirus disease 2019 (COVID-19) to establish potential relationships with mediastinal lymphadenopathy and clinical outcomes.
Methods: We compared the clinical characteristics and CT findings of COVID-19 patients from a nationwide multicenter cohort who were grouped based on the presence or absence of mediastinal lymphadenopathy. Differences between clinical characteristics and CT findings in these groups were analyzed. Univariate and multivariate analyses were performed to determine the impact of mediastinal lymphadenopathy on clinical outcomes.
Results: Of the 344 patients included in this study, 53 (15.4%) presented with mediastinal lymphadenopathy. The rate of diffuse alveolar damage pattern pneumonia and the visual CT scores were significantly higher in patients with mediastinal lymphadenopathy than in those without (P < 0.05). A positive correlation between the number of enlarged mediastinal lymph nodes and visual CT scores was noted in patients with mediastinal lymphadenopathy (Spearman's ρ = 0.334, P < 0.001). Multivariate analysis showed that mediastinal lymphadenopathy was independently associated with a higher risk of intensive care unit (ICU) admission (odds ratio, 95% confidence interval; 3.25, 1.06-9.95) but was not significantly associated with an increased risk of in-hospital death in patients with COVID-19.
Conclusion: COVID-19 patients with mediastinal lymphadenopathy had a larger extent of pneumonia than those without. Multivariate analysis adjusted for clinical characteristics and CT findings revealed that the presence of mediastinal lymphadenopathy was significantly associated with ICU admission.
Keywords: COVID-19; Computed Tomography; Intensive Care Unit; Mediastinal Lymphadenopathy; Pneumonia.
. 2022 Jun 6;37(22):e78.
doi: 10.3346/jkms.2022.37.e78.
Impact of Mediastinal Lymphadenopathy on the Severity of COVID-19 Pneumonia: A Nationwide Multicenter Cohort Study
Jong Eun Lee[SUP] 1 [/SUP], Won Gi Jeong[SUP] 2 [/SUP], Bo Da Nam[SUP] 3 [/SUP], Soon Ho Yoon[SUP] 4 [/SUP], Yeon Joo Jeong[SUP] 5 [/SUP], Yun-Hyeon Kim[SUP] 1 [/SUP], Sung Jin Kim[SUP] 6 [/SUP], Jin Young Yoo[SUP] 7 [/SUP]
Affiliations
- PMID: 35668683
- DOI: 10.3346/jkms.2022.37.e78
Abstract
Background: We analyzed the differences between clinical characteristics and computed tomography (CT) findings in patients with coronavirus disease 2019 (COVID-19) to establish potential relationships with mediastinal lymphadenopathy and clinical outcomes.
Methods: We compared the clinical characteristics and CT findings of COVID-19 patients from a nationwide multicenter cohort who were grouped based on the presence or absence of mediastinal lymphadenopathy. Differences between clinical characteristics and CT findings in these groups were analyzed. Univariate and multivariate analyses were performed to determine the impact of mediastinal lymphadenopathy on clinical outcomes.
Results: Of the 344 patients included in this study, 53 (15.4%) presented with mediastinal lymphadenopathy. The rate of diffuse alveolar damage pattern pneumonia and the visual CT scores were significantly higher in patients with mediastinal lymphadenopathy than in those without (P < 0.05). A positive correlation between the number of enlarged mediastinal lymph nodes and visual CT scores was noted in patients with mediastinal lymphadenopathy (Spearman's ρ = 0.334, P < 0.001). Multivariate analysis showed that mediastinal lymphadenopathy was independently associated with a higher risk of intensive care unit (ICU) admission (odds ratio, 95% confidence interval; 3.25, 1.06-9.95) but was not significantly associated with an increased risk of in-hospital death in patients with COVID-19.
Conclusion: COVID-19 patients with mediastinal lymphadenopathy had a larger extent of pneumonia than those without. Multivariate analysis adjusted for clinical characteristics and CT findings revealed that the presence of mediastinal lymphadenopathy was significantly associated with ICU admission.
Keywords: COVID-19; Computed Tomography; Intensive Care Unit; Mediastinal Lymphadenopathy; Pneumonia.